Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HP802-247 in Venous Leg Ulcers
NCT01737762Phase 3Completed
- Sponsor
- Healthpoint Biotherapeutics
- Start
- Nov 2012
- Primary completion
- Nov 2015
- Modality
- Implantable Devices, Implantable Hydrogels, Cell Therapies
- Countries
- 3
01
Overview
A Phase 3 trial of HP-802-247 in venous leg ulcer (VLU), sponsored by Healthpoint Biotherapeutics. Started Nov 2012; status: completed.
02
Drugs
HP-802-247
03
Conditions
venous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT01737762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01737762.